At Allorion Therapeutics, we focus on developing novel small molecule drugs against cancer and autoimmune diseases. Our team is comprised of experts in cancer biology and drug development. The fields we want to dive into include: • selecting well-validated targets with clear clinic development routes and discovering their modulators with distinct mechanisms of actions • building our innovative data and screening platforms for sustainable success • constructing chemical libraries with priorities on allosteric and covalent modulators and optimizing the libraries through the aid of AI Allorion has dual sites operating in Natick, Massachusetts and Guangzhou, China.